$182 Million is the total value of Knoll Capital Management, LLC's 38 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 15.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Buy | Biohaven Pharmactl Hldg Co L | $123,594,000 | +3.8% | 896,844 | +4.7% | 67.92% | +14.4% |
| APLT | Applied Therapeutics Inc | $9,238,000 | -46.1% | 1,032,123 | 0.0% | 5.08% | -40.6% | |
| ENTX | Entera Bio Ltd | $6,993,000 | -40.2% | 2,484,275 | 0.0% | 3.84% | -34.1% | |
| ORGS | Orgenesis, Inc. | $3,791,000 | -41.8% | 1,316,364 | 0.0% | 2.08% | -35.9% | |
| Anavex Life Sciemves Corp | $3,655,000 | -3.4% | 210,789 | 0.0% | 2.01% | +6.5% | ||
| EIGR | Eiger Biopharmaceuticals Inc | $3,603,000 | -22.3% | 694,232 | 0.0% | 1.98% | -14.4% | |
| CRBP | Corbus Pharmaceuticals HLDGS | $3,107,000 | -39.6% | 5,045,870 | 0.0% | 1.71% | -33.5% | |
| BX | Blackstone Group LP | $3,105,000 | +11.2% | 24,000 | 0.0% | 1.71% | +22.6% | |
| ALDX | Buy | Aldeyra Therapeutics Inc | $3,038,000 | -39.2% | 759,405 | +33.4% | 1.67% | -33.1% |
| ANET | Buy | Arista Networks Inc | $1,926,000 | +62.4% | 13,800 | +300.0% | 1.06% | +79.0% |
| AMD | Advanced Micro Deviced Inc | $1,777,000 | +39.9% | 12,350 | 0.0% | 0.98% | +54.3% | |
| CVS | CVS Health Corp | $1,463,000 | +18.9% | 14,500 | 0.0% | 0.80% | +31.2% | |
| TMO | Thermo Fischer Scientific Inc | $1,401,000 | +16.8% | 2,100 | 0.0% | 0.77% | +28.8% | |
| LUMN | Lumen Technologies Inc | $1,255,000 | +1.3% | 100,000 | 0.0% | 0.69% | +11.7% | |
| ALT | Altimmune Inc | $1,218,000 | -19.0% | 132,978 | 0.0% | 0.67% | -10.8% | |
| BAH | Booz Allen Hamilton HLDG CORcl a | $1,071,000 | +3.8% | 13,000 | 0.0% | 0.59% | +14.4% | |
| MO | Altria Group Inc | $1,064,000 | +3.0% | 22,700 | 0.0% | 0.58% | +13.6% | |
| V | Visa | $1,051,000 | -2.7% | 4,850 | 0.0% | 0.58% | +7.2% | |
| ASML | ASML Holdings | $1,014,000 | +11.2% | 1,280 | 0.0% | 0.56% | +22.4% | |
| GLW | Corning Inc | $968,000 | -0.3% | 26,600 | 0.0% | 0.53% | +9.9% | |
| OSK | New | OSHKOSH CORP | $925,000 | – | 8,450 | +100.0% | 0.51% | – |
| ABEO | Sell | Abeona Therapeutics Inc | $651,000 | -79.7% | 2,215,740 | -22.5% | 0.36% | -77.6% |
| OR | OSISKO GOLD ROYALTIES LTD | $579,000 | +62.2% | 190,000 | 0.0% | 0.32% | +78.7% | |
| SA | SEABRIDGE GOLD INC | $528,000 | +6.9% | 32,000 | 0.0% | 0.29% | +17.9% | |
| FNV | FRANCO NEV CORP | $519,000 | +6.6% | 3,750 | 0.0% | 0.28% | +17.3% | |
| MMX | MAVERIX METALS INC | $501,000 | -2.5% | 115,000 | 0.0% | 0.28% | +7.4% | |
| KL | KIRKLAND LAKE GOLD LTD | $451,000 | +0.9% | 10,750 | 0.0% | 0.25% | +11.2% | |
| BTAI | BioXCel Therapeutics Inc | $407,000 | -32.9% | 20,000 | 0.0% | 0.22% | -26.1% | |
| PAAS | PAN AMERN SILVER CORP | $407,000 | +113.1% | 8,200 | 0.0% | 0.22% | +135.8% | |
| SILV | SILVERCREST METALS INC | $381,000 | +30.0% | 42,000 | 0.0% | 0.21% | +43.2% | |
| AG | New | FIRST MAJESTIC silver corp | $376,000 | – | 33,000 | +100.0% | 0.21% | – |
| AEM | AGNICO EAGLE MINES LTD | $367,000 | +2.5% | 6,900 | 0.0% | 0.20% | +12.8% | |
| MAG | MAG SILVER CORP | $341,000 | +21.8% | 17,300 | 0.0% | 0.19% | +33.6% | |
| EQX | EQUINOX GOLD CORP | $308,000 | +2.7% | 45,500 | 0.0% | 0.17% | +12.7% | |
| SNGX | Sell | Soligenix Inc. | $288,000 | -65.5% | 436,580 | -44.6% | 0.16% | -62.0% |
| ANVS | Annovis | $250,000 | -44.6% | 14,210 | 0.0% | 0.14% | -39.1% | |
| AGTC | Applied genetic therapies | $190,000 | -36.9% | 100,000 | 0.0% | 0.10% | -30.7% | |
| ANGN | Angion BioMedica Corp | $174,000 | -70.3% | 60,000 | 0.0% | 0.10% | -67.1% | |
| FSM | Exit | FORTUNA SILVER MINES INC | $0 | – | -43,700 | -100.0% | -0.09% | – |
| SVM | Exit | SILVERCORP METALS INC | $0 | – | -70,000 | -100.0% | -0.13% | – |
| XCUR | Exit | Exicure | $0 | – | -801,922 | -100.0% | -0.48% | – |
| VMW | Exit | VMWare Inc | $0 | – | -6,950 | -100.0% | -0.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Aldeyra Therapeutics Inc | 35 | Q3 2023 | 31.6% |
| Corbus Pharmaceuticals HLDGS | 30 | Q3 2022 | 46.5% |
| Abeona Therapeutics Inc | 30 | Q3 2022 | 34.8% |
| Biohaven Pharmactl Hldg Co L | 26 | Q3 2023 | 79.6% |
| Entera Bio Ltd | 22 | Q3 2023 | 7.8% |
| Ampio Pharmaceuticals Inc. | 21 | Q2 2018 | 11.0% |
| Soligenix Inc. | 20 | Q3 2022 | 1.7% |
| Eiger Biopharmaceuticals Inc | 19 | Q3 2022 | 5.8% |
| Applied Therapeutics Inc | 18 | Q3 2023 | 19.7% |
| Alcobra Ltd | 18 | Q3 2017 | 6.5% |
View Knoll Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HOOKIPA Pharma Inc. | June 20, 2023 | 5,517,385 | 6.8% |
| Applied Therapeutics Inc. | January 23, 2023 | 3,450,000 | 7.2% |
| Orgenesis Inc. | August 14, 2020 | 1,316,364 | 5.9% |
| Corbus Pharmaceuticals Holdings, Inc. | February 14, 2020 | 5,045,870 | 7.1% |
| ABEONA THERAPEUTICS INC. | February 14, 2018 | 2,359,767 | 5.0% |
| SOLIGENIX, INC. | November 13, 2017 | 870,000 | 9.9% |
| ABEONA THERAPEUTICS INC. | February 14, 2017 | 2,359,767 | 5.9% |
| ALCOBRA LTD. | February 14, 2017 | 1,205,498 | 4.4% |
| Ampio Pharmaceuticals, Inc. | February 14, 2017 | 2,738,322 | 4.8% |
| RITTER PHARMACEUTICALS INC | February 14, 2017 | 952,434 | 8.2% |
View Knoll Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-16 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-04 |
| 13F-HR | 2023-08-15 |
| SC 13G | 2023-06-20 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-23 |
| 13F-HR | 2022-11-14 |
View Knoll Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.